Mergers and Acquisitions as a Consequence of Declining Innovation Productivity in Pharmaceuticals: Evidence from Croatia

Davor Mance, Nenad Vretenar and Antonija Gudelj

Journal of Innovative Business and Management, 2020, vol. 12, issue 1, 1-8

Abstract: Declining productivity of pharmaceutical innovation resulted in an increased number of mergers & acquisitions in the pharmaceutical industry. Increased investments into research & development lack the resulting increases in patentable new substances.

Keywords: mergers and acquisitions; pharmaceutical industry; research and development (search for similar items in EconPapers)
JEL-codes: L25 N84 (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://journal.doba.si/repec/pdf/12_2020_1_Mergers.pdf (application/pdf)
https://journal.doba.si/OJS/index.php/jimb/article/view/10.32015 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dob:journl:v:12:y:2020:i:1:a:1

DOI: 10.32015/JIBM/2020-12-1-1

Access Statistics for this article

Journal of Innovative Business and Management is currently edited by dr. Rasto Ovin

More articles in Journal of Innovative Business and Management from DOBA Faculty Contact information at EDIRC.
Bibliographic data for series maintained by Tatjana Gorjup Hlade ().